Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for FOXD1_FOXO1_FOXO6_FOXG1_FOXP1
Z-value: 1.29
Motif logo
Transcription factors associated with FOXD1_FOXO1_FOXO6_FOXG1_FOXP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
FOXD1
|
ENSG00000251493.2 | forkhead box D1 |
|
FOXO1
|
ENSG00000150907.6 | forkhead box O1 |
|
FOXO6
|
ENSG00000204060.4 | forkhead box O6 |
|
FOXG1
|
ENSG00000176165.7 | forkhead box G1 |
|
FOXP1
|
ENSG00000114861.14 | forkhead box P1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| FOXO1 | hg19_v2_chr13_-_41240717_41240735 | 0.52 | 1.6e-16 | Click! |
| FOXD1 | hg19_v2_chr5_-_72744336_72744359 | -0.37 | 2.0e-08 | Click! |
| FOXG1 | hg19_v2_chr14_+_29236269_29236287, hg19_v2_chr14_+_29234870_29235050 | -0.08 | 2.4e-01 | Click! |
Activity profile of FOXD1_FOXO1_FOXO6_FOXG1_FOXP1 motif
Sorted Z-values of FOXD1_FOXO1_FOXO6_FOXG1_FOXP1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of FOXD1_FOXO1_FOXO6_FOXG1_FOXP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.0 | 35.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 11.9 | 131.2 | GO:0033227 | dsRNA transport(GO:0033227) |
| 5.6 | 33.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 5.6 | 16.7 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 5.4 | 42.9 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 5.3 | 26.5 | GO:0097338 | response to clozapine(GO:0097338) |
| 5.1 | 30.3 | GO:0070417 | cellular response to cold(GO:0070417) |
| 4.8 | 24.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 4.5 | 18.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 4.4 | 26.5 | GO:0051025 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 4.3 | 56.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 4.3 | 34.6 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 3.7 | 21.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 3.5 | 28.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 3.5 | 13.8 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 3.4 | 13.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 3.4 | 10.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 3.2 | 51.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 3.0 | 20.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 2.9 | 8.7 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 2.8 | 8.4 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 2.7 | 16.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 2.7 | 10.7 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 2.4 | 48.7 | GO:0002347 | response to tumor cell(GO:0002347) |
| 2.3 | 7.0 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 2.2 | 21.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 2.0 | 6.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 2.0 | 30.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 2.0 | 6.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 1.9 | 1.9 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 1.9 | 5.7 | GO:0045658 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.8 | 9.1 | GO:0051029 | rRNA transport(GO:0051029) |
| 1.8 | 14.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 1.7 | 13.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 1.6 | 12.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 1.6 | 25.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.6 | 4.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 1.6 | 6.3 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 1.6 | 11.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.5 | 9.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 1.5 | 6.1 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.5 | 20.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 1.5 | 5.9 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 1.5 | 7.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) histone H2A phosphorylation(GO:1990164) |
| 1.4 | 4.3 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 1.4 | 7.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.3 | 5.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 1.3 | 6.5 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.3 | 3.9 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.2 | 8.5 | GO:0009597 | detection of virus(GO:0009597) |
| 1.2 | 7.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 1.2 | 3.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 1.1 | 7.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 1.1 | 11.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.1 | 2.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 1.1 | 5.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 1.0 | 4.2 | GO:0060613 | fat pad development(GO:0060613) |
| 1.0 | 11.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 1.0 | 21.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 1.0 | 14.7 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 1.0 | 4.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.9 | 17.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.9 | 24.7 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.9 | 3.5 | GO:1905073 | ossification involved in bone remodeling(GO:0043932) frontal suture morphogenesis(GO:0060364) occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.9 | 7.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.9 | 15.3 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.9 | 7.7 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.8 | 5.9 | GO:2000332 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.8 | 15.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.8 | 0.8 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.8 | 8.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.8 | 8.2 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.8 | 4.0 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.8 | 8.6 | GO:0090232 | peripheral nervous system myelin maintenance(GO:0032287) positive regulation of spindle checkpoint(GO:0090232) |
| 0.8 | 2.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.7 | 18.4 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.7 | 2.9 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.7 | 8.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.7 | 1.4 | GO:0003417 | growth plate cartilage development(GO:0003417) cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.7 | 3.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.7 | 5.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.7 | 2.8 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.7 | 4.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.7 | 2.8 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.7 | 4.1 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.7 | 26.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.7 | 7.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.6 | 10.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.6 | 5.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.6 | 1.9 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.6 | 7.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.6 | 6.9 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.6 | 4.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
| 0.6 | 1.7 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.6 | 5.6 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.5 | 3.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.5 | 6.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.5 | 2.7 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 0.5 | 5.3 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.5 | 19.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.5 | 14.8 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.5 | 0.5 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 0.5 | 1.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.5 | 1.9 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.5 | 4.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.5 | 5.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
| 0.5 | 0.9 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.5 | 17.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.4 | 1.3 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
| 0.4 | 3.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 | 2.2 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.4 | 2.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.4 | 1.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.4 | 18.0 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.4 | 4.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.4 | 2.0 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.4 | 32.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.4 | 9.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.4 | 1.5 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
| 0.4 | 1.9 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.4 | 1.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.4 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 3.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.3 | 2.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.3 | 0.7 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
| 0.3 | 21.8 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.3 | 1.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.3 | 3.0 | GO:0032329 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
| 0.3 | 5.9 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.3 | 1.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 | 1.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.3 | 2.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.3 | 2.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 | 3.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.3 | 4.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.3 | 1.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.3 | 1.4 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
| 0.3 | 4.4 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.3 | 8.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.3 | 2.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.3 | 1.3 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.3 | 3.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.3 | 4.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.3 | 5.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.3 | 4.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 | 1.7 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.2 | 0.7 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
| 0.2 | 0.5 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.2 | 5.6 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.2 | 0.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.2 | 1.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.2 | 17.4 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.2 | 1.7 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.2 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
| 0.2 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.2 | 5.3 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.2 | 3.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 | 2.5 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 9.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.2 | 0.4 | GO:0071883 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.2 | 6.9 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.2 | 5.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.2 | 2.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 1.5 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 0.9 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.2 | 0.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 | 4.7 | GO:0072663 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.2 | 1.1 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.2 | 1.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.2 | 2.8 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 | 0.7 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.2 | 1.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.2 | 7.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.2 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.2 | 44.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.2 | 3.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.2 | 2.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.2 | 3.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.2 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.2 | 0.2 | GO:0060620 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of cholesterol transporter activity(GO:0060694) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
| 0.2 | 9.9 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.2 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.1 | 22.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 | 0.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.1 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) interferon-beta biosynthetic process(GO:0045350) type I interferon biosynthetic process(GO:0045351) regulation of interferon-alpha biosynthetic process(GO:0045354) regulation of interferon-beta biosynthetic process(GO:0045357) |
| 0.1 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
| 0.1 | 9.2 | GO:0048678 | response to axon injury(GO:0048678) |
| 0.1 | 6.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 | 2.4 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 6.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.1 | 2.5 | GO:0030155 | regulation of cell adhesion(GO:0030155) |
| 0.1 | 2.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.3 | GO:0048867 | stem cell fate determination(GO:0048867) |
| 0.1 | 0.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 6.0 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.1 | 0.4 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.5 | GO:0018032 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.1 | 1.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.5 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
| 0.1 | 1.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 2.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 0.4 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.1 | 0.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 3.5 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.1 | 1.6 | GO:0060348 | bone development(GO:0060348) |
| 0.1 | 1.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.5 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 0.1 | 1.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 | 2.6 | GO:0016577 | histone demethylation(GO:0016577) |
| 0.1 | 0.4 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 2.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 0.4 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.1 | 6.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.5 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.1 | 2.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.1 | 0.7 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.1 | 0.5 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 | 0.6 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.6 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 | 1.5 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 | 0.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.1 | 8.1 | GO:0007286 | spermatid development(GO:0007286) |
| 0.1 | 0.5 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 | 6.0 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.1 | 0.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.1 | 0.4 | GO:0010193 | response to ozone(GO:0010193) |
| 0.1 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 1.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.1 | 0.1 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
| 0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.1 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.1 | 0.9 | GO:0097341 | inhibition of cysteine-type endopepti |